Precision Medicine News and Research

RSS

Survey identifies key factors linked to pediatric safety events in out-of-hospital emergent care situations

A national survey of more than 750 emergency medical services providers conducted by researchers at Oregon Health & Science University identified airway management skills, personal anxiety and limited pediatric care proficiency among key factors that may contribute to pediatric safety events for children in out-of-hospital emergent care situations.

19 Aug 2015

RPCI researchers create outreach effort to improve public's participation in biomedical research

Roswell Park Cancer Institute researchers, together with input from African-American community leaders in Buffalo, have created an outreach effort that provides racial/ethnic minority and medically underserved communities with educational programs regarding the public's participation in biomedical research. The program is the basis of a recent study published by a team of local collaborators.

18 Aug 2015

NCI-MATCH phase II precision medicine trial opens through ECOG-ACRIN

The National Cancer Institute-Molecular Analysis for Therapy Choice (NCI-MATCH) phase II precision medicine trial, known to doctors as trial EAY131, is open through the ECOG-ACRIN Cancer Research Group.

18 Aug 2015

Dr. Samadi's Prostate Cancer Center now offers Oncotype DX genetic test

Revolutionary genetic test, Oncotype DX from Genomic Health, is now offered at Dr. Samadi's Prostate Cancer Center in New York City.

18 Aug 2015

Genomic Health announces Medicare coverage for Oncotype DX prostate cancer test

Genomic Health, Inc. today announced that Palmetto GBA, a Medicare Administrative Contractor (MAC) that assesses molecular diagnostic technologies, has issued its final local coverage determination (LCD) approving coverage of the Oncotype DX prostate cancer test for qualified Medicare patients throughout the United States.

17 Aug 2015

New ISCO-SCCA collaboration to elevate standard of monthly virtual personalized tumor board

The Idaho Society of Clinical Oncology held its annual Board of Directors retreat in Sun Valley, ID on July 24-26, 2015. The focus for the retreat was how to discuss strategies to improve the care of cancer patients in Idaho. During the meeting, ISCO board announced a partnership with the Seattle Cancer Care Alliance to collaborate with ISCO's monthly virtual personalized tumor board.

17 Aug 2015

New research could help develop precision medicine for primary aldosteronism

Each of your kidneys wears a little yellow cap that helps keep your blood pressure in check, and much more. But in some people, it starts running amok, pumping out a hormone that sends blood pressure sky-high.

13 Aug 2015

Sorrento, TNK Therapeutics to exclusively license NanoVelcro CTC assay from CytoLumina and FetoLumina

Sorrento Therapeutics, Inc. announced today that it as well as its wholly-owned subsidiary TNK Therapeutics, Inc. have entered into a binding term sheet to exclusively license the NanoVelcro Circulating Tumor Cell (CTC) profiling assay technology from CytoLumina Technologies Corp. and FetoLumina Technologies Corp., two privately-held sister biotechnology companies in Los Angeles, California.

11 Aug 2015

Statisticians create new technique that helps doctors to optimize dose of cancer treatments

A new technique developed by statisticians that is helping doctors optimize the dose of a new cancer treatment patients receive in phase I/ II clinical trials was presented today by Juhee Lee, assistant professor of applied mathematics and statistics at the University of California, Santa Cruz, during a session at the 2015 Joint Statistical Meetings (JSM 2015) in Seattle.

11 Aug 2015

Barbara Ann Karmanos Cancer Institute, Wayne State University participate in NCI MATCH Trial

The Barbara Ann Karmanos Cancer Institute, in partnership with Wayne State University School of Medicine, is one of the lead academic centers participating in the National Cancer Institute's (NCI) MATCH (Molecular Analysis for Therapy Choice) Trial in the United States, set to begin in the next few weeks.

11 Aug 2015

Roche establishes strategic alliance with Diagnostic Laboratory Services

Roche announced today the establishment of a strategic alliance with Diagnostic Laboratory Services of Aiea, Hawaii, that designates the company as a Roche Molecular Center of Excellence (MCOE) for the next five years.

From Roche Sequencing and Life Science 10 Aug 2015

Leading public health scholars argue that increasing national focus on precision medicine misguided

The increasing national focus on personalized or 'precision' medicine is misguided, distracting from broader investments to reduce health inequities and address the social factors that affect population health, two leading public health scholars argue in the New England Journal of Medicine.

7 Aug 2015

Researchers use new dimensional method to distinguish between expectable and worrisome childhood misbehavior

Researchers at Northwestern University are using a novel dimensional method for distinguishing misbehavior that is expectable in early childhood versus that which is cause for clinical concern.

4 Aug 2015

California Initiative to Advance Precision Medicine selects two demonstration projects

Two demonstration projects that aim to yield quick results for patients have been selected by the new California Initiative to Advance Precision Medicine, a public-private effort launched by Governor Edmund G. Brown Jr.

4 Aug 2015

Ironshore partners with Restore Health to participate in HLD-200 clinical trial to treat ADHD

Ironshore Pharmaceuticals & Development, Inc. has signed an agreement with Restore Health, a company specializing in personalized medicine, to participate in the fulfillment of a double-blind clinical trial, designed to evaluate the safety and efficacy of HLD-200, a new drug in development to treat Attention-deficit/hyperactivity disorder (ADHD).

4 Aug 2015

NYSCF scientists design new robotic platform to automate generation of patient-specific stem cells

Scientists at The New York Stem Cell Foundation Research Institute successfully designed a revolutionary, high-throughput, robotic platform that automates and standardizes the process of transforming patient samples into stem cells.

4 Aug 2015

Illinois Health and Science acquires IBA Molecular North America

IBA Molecular, a global leader in the manufacture and distribution of radiopharmaceuticals, announced today the completion of the previously announced sale of its US operations, IBA Molecular North America, Inc., to Illinois Health and Science (IHS), a non-profit healthcare system based in Decatur, Illinois.

3 Aug 2015

Precision Medicine News and Research

Survey identifies key factors linked to pediatric safety events in out-of-hospital emergent care situations

RPCI researchers create outreach effort to improve public's participation in biomedical research

NCI-MATCH phase II precision medicine trial opens through ECOG-ACRIN

Dr. Samadi's Prostate Cancer Center now offers Oncotype DX genetic test

Genomic Health announces Medicare coverage for Oncotype DX prostate cancer test

New ISCO-SCCA collaboration to elevate standard of monthly virtual personalized tumor board

New research could help develop precision medicine for primary aldosteronism

Sorrento, TNK Therapeutics to exclusively license NanoVelcro CTC assay from CytoLumina and FetoLumina

Statisticians create new technique that helps doctors to optimize dose of cancer treatments

Barbara Ann Karmanos Cancer Institute, Wayne State University participate in NCI MATCH Trial

Roche establishes strategic alliance with Diagnostic Laboratory Services

Leading public health scholars argue that increasing national focus on precision medicine misguided

Researchers use new dimensional method to distinguish between expectable and worrisome childhood misbehavior

California Initiative to Advance Precision Medicine selects two demonstration projects

Ironshore partners with Restore Health to participate in HLD-200 clinical trial to treat ADHD

NYSCF scientists design new robotic platform to automate generation of patient-specific stem cells

Illinois Health and Science acquires IBA Molecular North America

BGI to hold 10th International Conference on Genomics in October

Discovery paves way for new therapeutic approaches to treat fatal leukemia in children

TGen scientist named a recipient of 2015 Bisgrove Scholars award

Editorial Focus eBook - Proteomics eBook

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Applications Engineer

Latest News